Prof Orkin is Professor of HIV Medicine at Queen Mary University of London and a Consultant Physician at Barts Health NHS Trust. She is the immediate past Chair of BHIVA, President-elect of the Medical Women’s Federation and a member of the governing council for IAS. Her specialist interest is antiretroviral therapy and is also the Clinical Lead for COVID-19 studies at Barts Health.

Prof Behrens is an internist, infectious disease specialist, and Professor for T Cell Immunology in the Department for Clinical Immunology and Rheumatology at Hannover Medical School, Hannover, Germany. He is an internationally recognised expert on HIV therapy, related metabolic side effects, and co-morbidities.

Prof Corbeau started his academic career in Cancerology, Infectious Diseases, Rheumatology and Immunology and is currently Professor of Medicine and Head of the Immunology Department at the University Hospital of Nîmes. He is also the Head of a Research Group at the Institute for Human Genetics at Montpellier. He has worked as an MD and a researcher from the beginning of the HIV epidemic and is now focusing on immune activation in people living with HIV.